From 16 to 18,August,2023,Medlab Asia & Asia Health is open in Bangkok,Thailand.As an international medical laboratory equipment and medical equipment exhibition in Thailand,is the premier medical event in the ASEAN region and the most valuable platform in the region. It is expected that there will be More than 7,500 professionals attended the conference, including representatives from all over Asia, industry experts, distributors and laboratory executives.
VACURE Biotech Brought 2 Self-Developed Diagnostic POCT
Platforms With Stable Performance And The Latest Fist Products.
They Are LYOFIA® Platform,Which Is Strip Microfluidic POCT Detection Meeting 3 Different Need,And DISKFLU® Platform,Which Is Panel Microfluidic POCT Detection,Benefiting Patients Get Accurate Clinical Evidences Of A Wide Range Of Diseases In 5-15 Minutes.
Malaysia Partners And Clinical Experts From Thailand Gave High Quality Feedback On Maternal And Children Detection Series Products,Such As VitaminD,VitaminB12,LH,Β-HCG,Prolaction Etc,Which Are Comparable To Chemiluminescent Detection, And Successfully Reached A Cooperation On The First Day Of The Exhibition.
Products at a glance
Part 1 LYOFIA® platform
|
|
LYOFIA-I |
| Small and Fast | |
| · Single Channel | |
| · Equipped with an incubator |
| LYOFIA8 |
|
| Small and Portable | |
| · 8 Channels,8 samples at a time | |
| · 96 test/h | |
| · Built-in incubator | |
| · Support continuous sample processing |
Part 2 DISKFLU® Platform
|
|
DISKFLU |
| Small but Smart | |
| · Single Channel | |
| · Self-contained centrifuge | |
| · 15mins, 9 parameters in 1 |
Part 3 Local Characteristic Gifts
About VACURE
VACURE Biotech is a high-tech enterprise focusing on the field of in vitro diagnostic (IVD) point-of-care testing (POCT). The company has gathered a large number of R&D personnel (accounting for 39%) such as the Provincial Thousand Talents Program. Based on self-developed patented core technologies such as microfluidic chip design, time-resolved fluorescent nanomaterials, and inkjet freeze-drying, through a number of underlying technological innovations, independent The fluorescent immunoassay quantitative detection platform LYOFIA system has been developed, the DISKFLU disc microfluidic immunological joint detection chip system has been iteratively upgraded, and the GENFLU microfluidic molecular integrated POCT detection system has been deployed to create POCT immunological and molecular products with excellent performance, realizing raw materials, instruments and The whole chain of reagents is self-developed and self-produced. Since 2023, the products have been exported to 50+ countries at home and abroad.
BOOTH INFORMATION
DATE：16-18,August
ADD.：IMPACT Exhibition
BOOTH：H6.F23
Don't miss out on the chance to be a part of this essential industry event and help shape the future of health.